Coronary Atherosclerosis in Patients With Cancer and Survivors
Published: February 09, 2026
- Cancer and atherosclerotic cardiovascular disease (ASCVD) share common risk factors—including chronic inflammation, aging, and lifestyle behaviors—and cancer therapies may accelerate atherosclerosis development.
- Cardiovascular risk assessment should begin at the time of cancer diagnosis, with ongoing surveillance using tools such as cardiac CT and stress testing to guide preventive strategies and detect subclinical disease.
- ASCVD in cancer patients requires a multidisciplinary approach involving oncology, cardiology, and imaging specialists to deliver personalized, coordinated care across the treatment continuum.
Supporting Materials
Recommended Reading
- Equity in Cardio-Oncology Care and Research
- Cardiovascular Imaging in Contemporary Cardio-Oncology
- Cardio-Oncology Drug Interactions
- Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors
- 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain